AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2018
Jun 14, 2018
32853_dirs_2018-06-13_968888f2-a9d1-4064-b95c-2239f78e7b6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-06-11
Reporting Person: Linthwaite Stephen Christopher (President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-11 | Restricted Stock Units | $ | A | 125000 | Acquired | Common Stock (125000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 125871 | Direct |
Footnotes
F1: Includes 5,000 shares purchased on May 31, 2018 under the Company's 2017 Employee Stock Purchase Plan.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
F3: 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date.